glp 1 drugs news GLP-1 Medications for Weight Loss: How to Get Started | GLP-1 weight loss drugs are

GLP-1 RAs are recommended in the treatment guidelines by the American Diabetes Association as well as the American Association of Clinical Endocrinology (AACE) Consensus Statement & European Society of Cardiology for type 2 diabetes mellitus patients with co-morbidities, like established atherosclerotic cardiovascular disease and obesity

In reality, these medications are just tools they support your journey but dont replace the need for healthy eating and exercise

To date, clinical data have been reported for two dual GIP/GLP-1 receptor agonists

518,519,520,521 Hepatocellular carcinoma (HCC) Initially developed for treating diabetes, GLP-1RAs have shown potential in treating NASH, which is closely related to HCC

Glucagonlike peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans

117 Additionally, to improve patient compliance, it is crucial to extend the drugs half-life